Akihiro Tomoyasu
Directeur/Bestuurslid bij KRINGLE PHARMA, INC.
Profiel
Akihiro Tomoyasu currently works at Kringle Pharma, Inc., as Director from 2016, KinoPharma, Inc., as Director from 2015, PharmaBio Corp., as Outside Director from 2020, HuLA immune, Inc., as Director, GenAhead Bio, Inc., as Outside Director from 2018, and MyMetagenome Co. Ltd., as Director from 2016.
Actieve functies van Akihiro Tomoyasu
| Bedrijven | Functie | Begin |
|---|---|---|
| KRINGLE PHARMA, INC. | Directeur/Bestuurslid | 01-12-2016 |
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Directeur/Bestuurslid | 01-02-2019 |
| GenAhead Bio, Inc. | Directeur/Bestuurslid | 01-07-2018 |
| MyMetagenome Co. Ltd. | Directeur/Bestuurslid | 01-02-2016 |
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | 01-12-2015 |
PharmaBio Corp.
 PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Directeur/Bestuurslid | 01-12-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KRINGLE PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
HuLA immune, Inc.
HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Health Technology |
| GenAhead Bio, Inc. | |
| MyMetagenome Co. Ltd. | |
KinoPharma, Inc.
KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Health Technology |
PharmaBio Corp.
PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Health Technology |